Introducing the CELOX™ PPH

Affordable. Rapid. Effective.

Book a product demo
Download product PDF

CELOX™ PPH in partnership with Maternity by Kimal to advance maternal care for every mother

1 in 4 births in England result in PPH. Rapid, effective control is key to improving patient outcomes.

CELOX™ PPH is an advanced, patented haemostatic impregnated gauze that rapidly and effectively controls PPH, working independently of the patient’s natural clotting mechanism.

Over a decade of clinically proven efficacy. Data(Ref 1,2) demonstrates:

100%

successful haemostasis
for grade 1 and 2 bleeding
(up to 2500mL) in all
deliveries1.

96%

haemostasis for grade
1 to 3 bleeding (up to
8000mL) in all
vaginal deliveries1

78%

reduction in
hysterectomies in
comparison to the
current standard of care2.

A Compassionate Response

CELOX™ PPH is already in a number of leading European National PPH guidelines, including Germany, Switzerland, and Austria.

How does CELOX™ PPH work?

Book a product demo
Download product PDF

Absorbs the fluid from blood cells to form a gel plug

Adheres to surrounding tissue to keep the plug in place

Creates an environment that allows clot formation under the gel plug

Following gauze removal, any residual gelled material will be expelled through the lochia or menstruation fluids

With 17+ years of leading the way in global management of haemostasis using CELOX™ technology across trauma, emergency services, and military applications.

Over the past 12+ years, CELOX™ PPH has emerged as a remarkable treatment option for postpartum haemorrhage (PPH). Notably, we have witnessed a substantial reduction in hysterectomy rates following its implementation.”

Prof. Dr. Wolfgang Henrich, Charite Hospital, Berlin